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First Identification of Compound Heterozygous  
FKRP Mutations in a Korean Patient with  
Limb-Girdle Muscular Dystrophy
Dystroglycanopathies are a genetically and clinically heterogeneous group of muscular 
dystrophies that are characterized by reduced glycosylation of α-dystroglycan. Among 18 
causative genes, the fukutin-related protein (FKRP; MIM 606596) gene is the most common 
cause in Caucasians.1 However, FKRP mutations have rarely been found in the Asian pop-
ulation,2 and have not been reported previously in Korea. Herein we report novel com-
pound FKRP mutations in a patient with myopathy, which represents the first reported case 
in Korea.
A 43-year-old female (II-4) (Fig. 1A) was the fourth child of nonconsanguineous healthy 
Korean parents who achieved normal motor milestones after birth. She first noticed diffi-
culty in climbing stairs at age 7 years, but muscle weakness did not progress. At the age of 
23 years the patient perceived the progression of muscle weakness and was admitted to our 
institute. She displayed proximal weakness, especially in the pelvic girdle muscles. Mild 
winged scapulae and lordosis were also observed. No sensory deficits, joint contracture, 
tongue hypertrophy, or mental retardation were apparent. Her serum creatine kinase level 
was markedly elevated, at 2,439 IU/L (reference value: <185 IU/L). An electrophysiologi-
cal study revealed a generalized myogenic process. No cardiac abnormality was observed. 
At the last examination, when she was 43 years old, she could walk with assistance.
The genetic cause of this patient’s myopathy was evaluated by performing targeted se-
quencing of 69 myopathy-causative genes including FKRP (Supplementary Information, 
Supplementary Table 1, 2, and 3 in the online-only Data Supplement). DNA fragments in 
the target regions were enriched by solution-based hybridization capture, followed by se-
quencing with an Illumina Hiseq2000 platform. The sequencing data were analyzed using 
a standard pipeline. Variants were then filtered further based on the patient’s phenotype. 
Compound heterozygous FKRP mutations of c.857G>C and c.1170_1171delGC were iden-
tified (Fig. 1B). The c.1170_1171delGC mutation has been reported previously in a Japa-
nese patient with congenital muscular dystrophy.2 However, the c.857G>C mutation was 
novel, and was not detected in 352 healthy controls, dbSNP138, or the 1000 Genomes 
Database (September 2014 release). In silico analysis using SIFT and PolyPhen2 predicted 
this mutation to be disease-causing. Genomic evolutionary rate profiling (GERP) indicated 
that the affected nucleotide is highly conserved (score=4.16), as became apparent upon in-
spection of the amino acid sequence in the altered region of the protein (Fig. 1C). Thus, the 
compound heterozygous FKRP mutations of c.1170_1171delGC and c.857G>C were deter-
mined to be the underlying cause of the myopathy in this patient.
FKRP mutations result in various clinical presentations from severe brain abnormality to 
mild limb-girdle muscular dystrophy.1 This variability makes it difficult to diagnose FKRP-
related muscular dystrophy based on clinical findings alone. Therefore, a step-by-step, clas-
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sical approach with assessment of muscle pathology, muscle 
immunoanalysis, and mutational analysis is needed for the 
diagnosis of FKRP-related muscular dystrophy. The findings 
of a recent study in Taiwan that employed this approach 
suggested that FKRP-related muscular dystrophy is under-
diagnosed, and not rare in the Asian population.3 However, 
this classical approach often fails to identify the causative 
gene due to pathological variability and the limited power of 
muscle immunoanalysis. Advances in next-generation se-
quencing, including targeted sequencing, have enabled the 
rapid and cost-effective analysis of many causative genes in 
uncategorized muscular dystrophy.4 In the present case, 
compound heterozygous FKRP mutations were identified us-
ing such next-generation sequencing.
In conclusion, novel compound heterozygous FKRP mu-
tations were identified in a patient with limb-girdle muscular 
dystrophy; this is the first reported case in Korea.
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Fig. 1. Pedigree, sequencing chromatograms, and conservation profile of the patient. A: Pedigree of a Korean patient with compound heterozy-
gous FKRP mutations. The filled symbol indicates the affected member; open symbols indicate unaffected members. B: Sequencing chromato-
grams of FKRP mutations c.857G>C and c.1170_1171delGC. C: Conservation analysis result of the c.857G>C mutation site. FKRP: fukutin-related 
protein.
